Vats Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 23-12-2024
- Paid Up Capital ₹ 4.00 M
as on 23-12-2024
- Company Age 9 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 Cr
as on 23-12-2024
- Satisfied Charges ₹ 3.00 M
as on 23-12-2024
- Revenue 155.07%
(FY 2023)
- Profit 43.26%
(FY 2023)
- Ebitda 32.55%
(FY 2023)
- Net Worth 23.31%
(FY 2023)
- Total Assets 208.43%
(FY 2023)
About Vats Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹1.50 Cr. The company has closed loans amounting to ₹3.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ashish Jha, Rani Kumari, Preeti Jha, and One other member serve as directors at the Company.
- CIN/LLPIN
U52310JH2015PTC003021
- Company No.
003021
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jul 2015
- Date of AGM
20 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jharkhand
Industry
Company Details
- Location
Singhbhum, Jharkhand, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Vats Biotech Private Limited offer?
Vats Biotech Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Gastrointestinal Drugs, Cardiovascular Drugs & Medication, Blood Pressure Medicine, Diabetes Medicine, Nutraceuticals & Dietary Supplements, Dietary Supplements, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Common Disease Medicines.
Who are the key members and board of directors at Vats Biotech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rani Kumari  | Additional Director | 17-Feb-2017 | Current |
| Preeti Jha | Additional Director | 17-Feb-2017 | Current |
| Ashish Jha | Director | 07-Jul-2015 | Current |
| Brajesh Singh | Additional Director | 12-Nov-2021 | Current |
Financial Performance of Vats Biotech.
Vats Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 155.07% increase. The company also saw a substantial improvement in profitability, with a 43.26% increase in profit. The company's net worth Soared by an impressive increase of 23.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vats Biotech?
Unlock access to Vats Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 17 Aug 2024 | ₹1.50 Cr | Open |
Others Creation Date: 03 Nov 2020 | ₹1.00 M | Satisfied |
Union Bank Of India Creation Date: 29 Jan 2016 | ₹2.00 M | Satisfied |
How Many Employees Work at Vats Biotech?
Vats Biotech has a workforce of 30 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vats Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vats Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
